American Healthcare REIT (AHR) Citi’s Miami Global Property CEO Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Citi’s Miami Global Property CEO Conference 2026 summary
29 Apr, 2026Market fundamentals and growth outlook
Senior housing and long-term care segments show strong supply-demand fundamentals, supporting robust organic earnings growth and favorable cost of capital, enabling external growth opportunities.
Guidance indicates nearly 18% NFFO per share growth at the midpoint, with a safe balance sheet at 3.4x net debt to EBITDA.
Sector benefits from demographic tailwinds, with 10,000 people turning 80 daily and limited new construction (less than 1% of stock under construction), supporting sustained growth.
Occupancy in RIDEA segments grew by 270-280 basis points last year, with continued demand expected as baby boomers age.
Revenue mix, reimbursement, and operator strategy
Trilogy segment leverages a mix of private pay, Medicare Advantage, and Medicaid, with private pay skilled nursing rates showing pricing power.
Trilogy partners selectively with Medicare Advantage plans offering the highest reimbursement, achieving over 8.5% growth in that business.
Shifting resident mix toward higher-reimbursement sources (Medicare, Medicare Advantage) is driving daily rate growth and reducing Medicaid exposure.
Trilogy’s integrated campus model (skilled nursing, assisted living, memory care, independent living) creates operational synergies and higher occupancy.
Operator selection, alignment, and scaling
Operator selection precedes real estate acquisition, with a rigorous, multi-year underwriting process focused on regional expertise and performance.
Management contracts with Trilogy are heavily incentive-based, aligned with EBITDA growth, and paid in stock, fostering strong operator alignment.
Trilogy’s scale and resources are leveraged to support regional operators, facilitating best practice sharing and helping them scale to meet projected demand shortfalls.
Latest events from American Healthcare REIT
- Double-digit NOI and FFO growth drive raised 2026 guidance and strong Q1 results.AHR
Q1 20268 May 2026 - Q3 2025 net income hit $56.6M with 16.4% NOI growth and raised 2025 guidance.AHR
Q3 202523 Apr 2026 - Double-digit NOI and FFO growth in 2025, with strong 2026 guidance and robust acquisition pipeline.AHR
Q4 202510 Apr 2026 - Proxy covers director elections, auditor ratification, and strong 2025 performance with 80% TSR.AHR
Proxy filing9 Apr 2026 - Double-digit NOI growth and strong occupancy highlight robust performance and future growth potential.AHR
Investor presentation2 Mar 2026 - Strong Q2 results, raised 2024 guidance, and improved leverage driven by SHOP and ISHC growth.AHR
Q2 20242 Feb 2026 - Strong organic growth and disciplined capital allocation drive value, led by the Trilogy platform.AHR
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong NOI and revenue growth, raised guidance, and improved leverage after key acquisitions.AHR
Q3 202414 Jan 2026 - Strong multi-year growth driven by managed care, Trilogy synergies, and portfolio optimization.AHR
Citi’s 30th Annual Global Property CEO Conference 202523 Dec 2025